X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bortezomib (2) 2
chemotherapy (2) 2
chemotherapy, adjuvant (2) 2
dexamethasone (2) 2
disease-free survival (2) 2
elderly-patients (2) 2
female (2) 2
humans (2) 2
index medicus (2) 2
italy (2) 2
kaplan-meier estimate (2) 2
male (2) 2
middle aged (2) 2
multiple myeloma (2) 2
multiple myeloma - diagnosis (2) 2
prednisone (2) 2
thalidomide (2) 2
thalidomide - adverse effects (2) 2
transplantation, autologous (2) 2
treatment outcome (2) 2
abridged index medicus (1) 1
adult (1) 1
australia (1) 1
bone marrow (1) 1
boronic acids - administration & dosage (1) 1
boronic acids - adverse effects (1) 1
cancer (1) 1
care and treatment (1) 1
clinical medicine (1) 1
clinical-trial (1) 1
combination therapy (1) 1
complications and side effects (1) 1
consolidation (1) 1
consolidation therapy (1) 1
cyclophosphamide (1) 1
cyclophosphamide - therapeutic use (1) 1
czech republic (1) 1
data collection (1) 1
dexamethasone - administration & dosage (1) 1
dexamethasone - adverse effects (1) 1
dexamethasone - therapeutic use (1) 1
dexamethasone combination (1) 1
disease progression (1) 1
dosage and administration (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
heart attacks (1) 1
heart failure (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation (1) 1
hematopoietic stem cell transplantation - adverse effects (1) 1
hematopoietic stem cell transplantation - mortality (1) 1
herpes-zoster (1) 1
high-dose melphalan (1) 1
iii trial (1) 1
induction (1) 1
initial treatment (1) 1
internal medicine (1) 1
maintenance chemotherapy (1) 1
medical colleges (1) 1
medicine, general & internal (1) 1
melphalan (1) 1
melphalan - therapeutic use (1) 1
multiple myeloma - drug therapy (1) 1
multiple myeloma - mortality (1) 1
multiple myeloma - surgery (1) 1
multiple myeloma - therapy (1) 1
neoadjuvant therapy - methods (1) 1
oncology (1) 1
ovarian cancer (1) 1
physiology (1) 1
prednisone - adverse effects (1) 1
prednisone - therapeutic use (1) 1
product development (1) 1
proportional hazards models (1) 1
pyrazines - administration & dosage (1) 1
pyrazines - adverse effects (1) 1
remission induction (1) 1
reoperation (1) 1
risk factors (1) 1
stem cells (1) 1
stem-cell transplantation (1) 1
studies (1) 1
survival (1) 1
thalidomide - administration & dosage (1) 1
thalidomide - analogs & derivatives (1) 1
thalidomide - therapeutic use (1) 1
time factors (1) 1
transplantation (1) 1
transplants & implants (1) 1
vtd (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1617 - 1629
Summary Background High-dose melphalan plus autologous stem-cell transplantation (ASCT) is the standard approach in transplant-eligible patients with newly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | ONCOLOGY | CONSOLIDATION THERAPY | INITIAL TREATMENT | THALIDOMIDE | BORTEZOMIB | INDUCTION | STEM-CELL TRANSPLANTATION | DEXAMETHASONE COMBINATION | ELDERLY-PATIENTS | MELPHALAN | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Melphalan - therapeutic use | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - therapeutic use | Thalidomide - analogs & derivatives | Multiple Myeloma - therapy | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Maintenance Chemotherapy | Chemotherapy, Adjuvant | Thalidomide - adverse effects | Prednisone - adverse effects | Multiple Myeloma - diagnosis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Disease Progression | Disease-Free Survival | Czech Republic | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Thalidomide - therapeutic use | Australia | Prednisone - therapeutic use | Medical colleges | Cyclophosphamide | Care and treatment | Chemotherapy | Dexamethasone | Multiple myeloma | Stem cells | Product development | Prednisone | Transplantation | Cancer | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.